Get started
Author

Semra Taş

Observed names: Semra TAŞ, Semra Tas
ORCID: 0000-0002-9441-9210
Observed ORCID: 0000-0002-9441-9210
OpenAlex ID: A5113391809
SUVmax-IPI as a New Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab
2025 · Nagihan Kolkıran, Atike Pınar Erdoğan, et al. · Current Oncology · 4
PDF
Prognostic Value of Systemic Inflammatory Markers in Locally Advanced or Metastatic Melanoma: A Real-World Analysis
2026 · Burçin Çakan Demirel, Semra Taş, et al. · Cancers · 3
PDF
Prognostic Value of ALBI Score and Lymphocyte-Associated Inflammation Markers in Advanced Hepatocellular Carcinoma: A Single Centre Retrospective Cross-Sectional Study
2024 · Melek ÖZDEMİR, Gamze GÖKOZ DOĞU, et al. · Namık Kemal Tıp Dergisi · 3
PDF
Vinorelbine Induced Serpentine Supravenous Hyperpigmentation
2022 · Ahsen Duygu YETUT, Semra TAŞ, et al. · Journal of Oncological Sciences · 3
PDF
Impact of HER2-Low Expression on Clinical Outcomes in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors
2026 · Şahin Bedir, Tanju Kapagan, et al. · Journal of Clinical Medicine · 2
PDF
The Royal Marsden Hospital Score Independently Predicts Overall Survival in Patients with De Novo Metastatic Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitors: A Multicenter Retrospective Analysis
2026 · Tolga Doğan, Semra Taş, et al. · Journal of Clinical Medicine · 1
PDF
Differential Metastatic Patterns and Prognostic Value of Systemic Inflammation Scores in Anaplastic Lymphoma Kinase Rearranged Versus Anaplastic Lymphoma Kinase Negative Non-Small Cell Lung Cancer
2026 · Melek Özdemir, Gamze Gököz Doğu, et al. · Cancers · 1
PDF
Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors—A Turkish Oncology Group Study
2025 · Safa Can Efil, Fatih Kus, et al. · Cancers · 1
PDF
Prevalence and Prognostic Significance of Positron Emission Tomography–Computed Tomography–Defined Low Skeletal Muscle Mass (Radiological Sarcopenia) in Metastatic Breast Cancer
2026 · Taliha Güçlü Kantar, Semra Taş, et al. · Cerrahpasa Medical Journal
PDF
Clinical Predictors of Progression-free Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Lu-177 PSMA: A Real-world Study
2026 · Taliha GÜÇLÜ KANTAR, Semra TAŞ, et al. · Journal of Oncological Sciences
PDF
Development of a Composite Risk Score and Real-world Outcomes in Advanced Pancreatic Adenocarcinoma: Prognostic Value of Baseline 18F-FDG PET/CT Metabolic Parameters
2026 · Taliha Güçlü Kantar, Tolga Doğan, et al. · Acta haematologica oncologica Turcica.
PDF
Prognostic Role of Inflammatory Indices and Real-World Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine
2026 · Taliha Güçlü Kantar, Tolga Doğan, et al. · Diagnostics
Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study
2026 · Anıl Karakayalı, Mustafa Seyyar, et al. · Medicina
On-treatment dNLR and metastatic burden predict survival in advanced non-small-cell lung cancer treated with nivolumab
2026 · Tolga Doğan, Semra Taş, et al. · Turkish Journal of Clinics and Laboratory
PDF
Inflammation-tumor burden interaction score stratifies survival after irinotecan-eluting bead chemoembolization for colorectal liver metastases
2026 · Tolga Doğan, Semra Taş, et al. · Frontiers in Medicine
PDF
Association of Post-Neoadjuvant Chemotherapy MRI and 18F-FDG PET/CT Findings with Tumor Response and Prognosis in Breast Cancer
2026 · Burçin Çakan Demirel, Semra Taş, et al. · Diagnostics
PDF
The Impact of the Systemic Immune-inflammation Index and the Systemic Inflammatory Response Index on Progression-free Survival and Overall Survival in Second-line Immunotherapy for Metastatic Non-small Cell Lung Cancer
2026 · Burçin Çakan Demirel, Şahin Bedir, et al. · Bagcilar Medical Bulletin
PDF
Role of Prognostic Nutritional Index and C-Reactive Protein/Albumin Ratio in Prognosis of Locally Advanced Nasopharyngeal Carcinoma
2026 · Taliha Güçlü Kantar, Tolga Doğan, et al. · Medicina
PDF
Meme Kanseri
2026 · Semra Taş, Ali Alper Solmaz, et al. · Akademisyen Kitabevi eBooks
PDF
HER2-Pozitif Metastatik Meme Kanserinde Tedavi Yaklaşımı
2026 · Semra Taş · Akademisyen Kitabevi eBooks
Real-World Outcomes of Treatment Approaches and the Impact of Systemic Inflammation Markers on Survival in Patients with Locally Advanced and Metastatic Laryngeal Cancer
2025 · Burçin Çakan Demirel, Semra Taş, et al. · Journal of Clinical Medicine
PDF
Prognostic Value of a New Marker, IBI Score and NLR Change in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors (Prognostic value of IBI score and NLR change in NSCLC)
2025 · Melek Özdemir, Gamze Gokoz Dogu, et al. · Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi
PDF
Kanserde Takip
2025 · Şermin Dinç Sonuşen, İbrahim Bilen, et al. · Akademisyen Kitabevi eBooks
PDF
The impact of SARS-CoV-2 infection on the survival in NSCLC patients undergoing immunotherapy
2025 · Melek Özdemir, Gamze Gokoz Dogu, et al. · Pamukkale Medical Journal
PDF
Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study
2025 · Furkan Ceylan, Selin Aktürk Esen, et al. · Medicina
PDF
Works count: 26
Citation count: 18
H-index: 3
I10-index:
Year
Topic
Type